[go: up one dir, main page]

Gratama et al., 1992 - Google Patents

Detection of multiple Epstein‐Barr viral strains in allogeneic bone marrow transplant recipients

Gratama et al., 1992

Document ID
435329116907122975
Author
Gratama J
Lennette E
Lönnqvist B
Oosterveer M
Klein G
Ringden O
Ernberg I
Publication year
Publication venue
Journal of medical virology

External Links

Snippet

We have previously shown in 3 allogeneic bone‐marrow transplant (BMT) recipients that complete replacement of recipient marrow was associated with the elimination of the pretransplant Epstein‐Barr virus (EBV) strain of the recipient. To study the kinetics of EBV …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses

Similar Documents

Publication Publication Date Title
Gratama et al. Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency.
FAUCI et al. Acquired immunodeficiency syndrome: epidemiologic, clinical, immunologic, and therapeutic considerations
HANTO et al. Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation
Campadelli‐Fiume et al. The novel receptors that mediate the entry of herpes simplex viruses and animal alphaherpesviruses into cells
Ahmed et al. T4+ T helper cell function in vivo: differential requirement for induction of antiviral cytotoxic T-cell and antibody responses
Dummer et al. Morbidity of cytomegalovirus infection in recipients of heart or heart-lung transplants who received cyclosporine
Thorley-Lawson The transformation of adult but not newborn human lymphocytes by Epstein Barr virus and phytohemagglutinin is inhibited by interferon: the early suppression by T cells of Epstein Barr infection is mediated by interferon.
Keay et al. Anti-idiotype antibodies that mimic gp86 of human cytomegalovirus inhibit viral fusion but not attachment
Rickinson et al. Long‐term T‐cell‐mediated immunity to Epstein‐Barr virus in man. II. Components necessary for regression in virus‐infected leukocyte cultures
Gratama et al. Detection of multiple Epstein‐Barr viral strains in allogeneic bone marrow transplant recipients
Fiore et al. The biological phenotype of HIV-1 is usually retained during and after sexual transmission
Gratama et al. EBNA size polymorphism can be used to trace Epstein-Barr virus spread within families
Masucci et al. Cellular immune defects to Epstein-Barr virus-determined antigens in young males
Hirsch Herpes group virus infections in the compromised host
Gratama et al. Serological and molecular studies of Epstein-Barr virus infection in allogeneic marrow graft recipients
Streicher et al. In vitro inhibition of human herpesvirus-6 by phosphonoformate
Wood Viral infections in neutropenia--current problems and chemotherapeutic control.
Fontana et al. Deficiency of natural killer activity, but not of natural killer binding, in patients with lymphoadenopathy syndrome positive for antibodies to HTLV-III
SULLIVAN Epstein-Barr virus and the X-linked lymphoproliferative syndrome
Rappocciolo et al. Association of alpha interferon production with natural killer cell lysis of U937 cells infected with human immunodeficiency virus
Hardy Jr et al. Deficiency Syndrome
Middeldorp et al. Killing of human cytomegalovirus-infected fibroblasts by antiviral antibody and complement
CA2083493C (en) Association between a human immunodeficiency virus-related retrovirus and sjogren's syndrome
Gibson et al. The activity of (S)-1-[(3-hydroxy-2-phosphonyl methoxy) propyl] cytosine (HPMPC) against equine herpesvirus-1 (EHV-1) in cell cultures, mice and horses
Vogt et al. Prospects for the prevention and therapy of infections with the human immunodeficiency virus